Angiotensin II type 2 receptor gene deficiency attenuates susceptibility to tobacco-specific nitrosamine-induced lung tumorigenesis: Involvement of transforming growth factor-β-dependent cell growth attenuation

Cancer Research

Volumn 65, Issue 17, 2005, Pages 7660-7665

  Kanehira, Tsutomu ^a   Tani, Tatsuo ^a   Takagi, Tetsuo ^a   Nakano, Yuichirou ^a   Howard, Eric F ^a   Tamura, Masaaki ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; ANGIOTENSIN 2 RECEPTOR; CARCINOGEN; NITROSAMINE; TRANSFORMING GROWTH FACTOR BETA;

ANGIOTENSIN II TYPE 2 RECEPTOR GENE DEFICIENCY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER SUSCEPTIBILITY; CELL COUNT; CELL CULTURE; CELL TYPE; CONTROLLED STUDY; CULTURE MEDIUM; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; LUNG CANCER; LUNG CARCINOGENESIS; LUNG FIBROBLAST; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR GENE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TOBACCO; WILD TYPE;

ANIMALS; CARCINOGENS; CELL GROWTH PROCESSES; COCARCINOGENESIS; FEMALE; FIBROBLASTS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MICE; NITROSAMINES; PROTEINS; RECEPTOR, ANGIOTENSIN, TYPE 2;

EID: 24744448246     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-0275     Document Type: Article

References (53)

1. Reddy MK, Baskaran K, Molteni A. Inhibitors of angiotensin-converting enzyme modulate mitosis and gene expression in pancreatic cancer cells. Proc Soc Exp Biol Med 1995;210:221-6.
2. Volpert OV, Ward WF, Lingen MW, et al. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J Clin Invest 1996;98:671-9.
3. Hu SI, Nicol DL, Gotley DC, et al. Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma. Br J Cancer 1998;77:880-3.
4. Prontera C, Mariani B, Rossi C, et al. Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma. Int J Cancer 1999;81:761-6.
5. Yoshiji H, Kuriyama S, Kawata M, et al. The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor. Clin Cancer Res 2001;7:1073-8.
6. Lever AF, Hole DJ, Gillis CR, et al. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 1998;352:179-84.
7. Johnston CI. Angiotensin-converting enzyme inhibitors. In: Robertson JIS, Nicholls MG, editors. The renin-angiotensin system. Vol. 2. Pathophysiology, therapeutics. London: Mosby; 1993. p. 1-87.
8. Maluccio M, Sharma V, Lagman M, et al. Angiotensin II receptor blockade: a novel strategy to prevent immunosuppressant-associated cancer progression. Transplant Proc 2001;33:1820-1.
9. Fujita M, Hayashi I, Yamashina S, et al. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res Commun 2002;294:441-7.
10. Stoll M, Unger T. Angiotensin and its AT2 receptor: new insights into an old system. Regul Pept 2001;99:175-82.
11. Thomas WG. Regulation of angiotensin II type 1 (AT1) receptor function. Regul Pept 1999;79:9-23.
12. Timmermans P, Wong P, Chiu A, et al. Angiotensin II receptor and angiotensin II receptor antagonists. Pharmacol Rev 1993;45:205-51.
13. Blume A, Herdegen T, Unger T. Angiotensin peptides and inducible transcription factors. J Mol Med 1999;77:339-57.
14. Xi XP, Graf K, Goetze S, et al. Central role of the MAPK pathway in Ang II-mediated DNA synthesis and migration in rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999;19:73-82.
15. Hu DE, Hiley CR, Fan TP. Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins-1 and -3 and angiotensin II in a rat sponge model. Br J Pharmacol 1996;117:545-51.
16. Otani A, Takagi H, Suzuma K, et al. Angiotensin II potentiates vascular endothelial growth factor-induced angiogenic activity in retinal microcapillary endothelial cells. Circ Res 1998;82:619-28.
17. Campbell SE, Katwa LC. Angiotensin II stimulated expression of transforming growth factor-β1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol 1997;29:1947-58.
18. Fujiyama S, Matsubara H, Nozawa Y, et al. Angiotensin AT(1) and AT(2) receptors differentially regulate angiopoietin-2 and vascular endothelial growth factor expression and angiogenesis by modulating heparin binding-epidermal growth factor (EGF)-mediated EGF receptor transactivation. Circ Res 2001;88:22-9.
19. Peng H, Moffett J, Myers J, et al. Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors. Mol Biol Cell 2001;12:449-62.
20. Viswanathan M, Saavedra JM. Expression of angiotensin II AT2 receptors in the rat skin during experimental wound healing. Peptides 1992;13:783-6.
21. Tamura M, Takagi T, Howard EF, et al. Induction of angiotensin II subtype 2 receptor-mediated blood pressure regulation in synthetic diet-fed rats. J Hypertens 2000;18:1239-46.
22. Bullock GR, Steyaert I, Bilbe G, et al. Distribution of type-1 and type-2 angiotensin receptors in the normal human lung and in lungs from patients with chronic obstructive pulmonary disease. Histochem Cell Biol 2001;115:117-24.
23. Senbonmatsu T, Saito T, Landon EJ, et al. A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy. EMBO J 2003;22:6471-82.
24. Nakajima M, Hutchinson HG, Fujinaga M, et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci U S A 1995;92:10663-7.
25. de Gasparo M, Siragy HM. The AT2 receptor: fact, fancy and fantasy. Regul Pept 1999;81:11-24.
26. Kambayashi Y, Bardhan S, Takahashi K, et al. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition. J Biol Chem 1993;268:24543-6.
27. Mukoyama M, Nakajima M, Horiuchi M, et al. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J Biol Chem 1993;268:24539-42.
28. Takagi T, Nakano Y, Takekoshi S, et al. Hemizygous mice for the angiotensin II type 2 receptor gene have attenuated susceptibility to azoxymethane-induced colon tumorigenesis. Carcinogenesis 2002;23:1235-41.
29. Abe M, Harpel JG, Metz CN, et al. An assay for transforming growth factor-β using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal Biochem 1994;216:276-84.
30. Ichiki T, Labosky PA, Shiota C, et al. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995;377:748-50.
31. Fekete E. A comparative morphological study of the mammary gland in a high and low tumor strain of mice. Am J Pathol 1938;14:557-83.
32. Shannon JM, Mason RJ, Jennings SD. Functional differentiation of alveolar type II epithelial cells in vitro: effects of cell shape, cell-matrix interactions and cell-cell interactions. Biochim Biophys Acta 1987;931:143-56.
33. Law BK, Chytil A, Dumont N, et al. Rapamycin potentiates transforming growth factor β-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells. Mol Cell Biol 2002;22:8184-98.
34. Tamura M, Wanaka Y, Landon EJ, et al. Intracellular sodium modulates the expression of angiotensin II subtype 2 receptor in PC12W cells. Hypertension 1999;33:626-32.
35. Gregoire M, Lieubeau B. The role of fibroblasts in tumor behavior. Cancer Metastasis Rev 1995;14:339-50.
36. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
37. Kim DH, Kim S-J. Transforming growth factor-β receptors: role in physiology and disease. J Biomed Sci 1996;3:143-58.
38. Markowitz SD, Roberts AB. Tumor suppressor activity of the TGF-β pathway in human cancers. Cytokine Growth Factor Rev 1996;7:93-102.
39. Massague J. TGF-β signal transduction. Annu Rev Biochem 1998;67:753-91.
40. Parenti A, Brogelli L, Donnini S, et al. ANG II potentiates mitogenic effect of norepinephrine in vascular muscle cells: role of FGF-2. Am J Physiol Heart Circ Physiol 2001;280:H99-107.
41. Gold LI, Parekh TV. Loss of growth regulation by transforming growth factor-β (TGF-β) in human cancers: studies on endometrial carcinoma. Semin Reprod Endocrinol 1999;17:73-92.
42. Kang SH, Bang YJ, Im YH, et al. Transcriptional repression of the transforming growth factor-β type I receptor gene by DNA methylation results in the development of TGF-β resistance in human gastric cancer. Oncogene 1999;18:7280-6.
43. Hecht SS. Biochemistry, biology, and carcinogenicity of tobacco-specific N-nitrosamines. Chem Res Toxicol 1998;11:559-603.
44. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 1999;91:1194-210.
45. Thaete LG, Gunning WT, Stoner GD, et al. Cellular derivation of lung tumors in sensitive and resistant strains of mice: results at 28 and 56 weeks after urethan treatment. J Natl Cancer Inst 1987;78:743-9.
46. Wang Y, Zhang Z, Yan Y, et al. A chemically induced model for squamous cell carcinoma of the lung in mice: histopathology and strain susceptibility. Cancer Res 2004;64:1647-54.
47. Fidler IJ. Critical factors in the biology of human cancer metastasis: twenty- eighth G.H.A. Clowes memorial award lecture. Cancer Res 1990;50:6130-8.
48. Fridman R, Giaccone G, Kanemoto T, et al. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines. Proc Natl Acad Sci U S A 1990;87:6698-702.
49. Bhowmick NA, Chytil A, Plieth D, et al. TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 2004;303:848-51.
50. Kim DK, Huh JE, Lee SH, et al. Angiotensin II stimulates proliferation of adventitial fibroblasts cultured from rat aortic explants. J Korean Med Sci 1999;14:487-96.
51. Wang R, Zagariya A, Ibarra-Sunga O, et al. Angiotensin II induces apoptosis in human and rat alveolar epithelial cells. Am J Physiol 1999;276:L885-9.
52. Bechara RI, Brown LA, Eaton DC, et al. Chronic ethanol ingestion increases expression of the angiotensin II type 2 (AT2) receptor and enhances tumor necrosis factor-α- and angiotensin II-induced cytotoxicity via AT2 signaling in rat alveolar epithelial cells. Alcohol Clin Exp Res 2003;27:1006-14.
53. Levy BI, Benessiano J, Henrion D, et al. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest 1996;98:418-25.